Misoprostol for postpartum hemorrhage in the study.doc

 PAGE \* MERGEFORMAT 8 Misoprostol for postpartum hemorrhage in the study [Abstract] Objective To observe the normal production of misoprostol, bleeding caesarean section efficacy and safety of the application. Methods 133 cases of cesarean section patients, 163 patients with normal production, are due to uterine atony postpartum hemorrhage were given oxytocin, misoprostol treatment, the amount of bleeding and side effects observed. Results cesarean section patients, oxytocin group blood loss was (639 + -232) mL, the amount of bleeding misoprostol group (575 + -152) mL, 2 group, the difference was statistically significant (P lt;0.01 normal full-term patients, postpartum hemorrhage, oxytocin group (582 + -212) mL, the amount of bleeding misoprostol group (480 + -204) mL, 2 group, the difference was statistically significant (P lt;0.05. Interim abortion patients, postpartum hemorrhage, oxytocin group (499 + -170) mL, the amount of bleeding misoprostol group (400 +-168mL, 2 group, the difference was statistically significant (P lt;0.05. Conclusions of misoprostol used in post-partum, can significantly reduce uterine inertia due to postpartum hemorrhage, particularly with poor contraction of the lower uterine segment, the effect better than oxytocin, and adverse effects. [Keywords:] misoprostol for postpartum hemorrhage, fatigue reduction Five maternal causes of death include: postpartum hemorrhage, pregnancy induced hypertension, heart disease, pregnancy, puerperal infection, amniotic fluid embolism. Postpartum hemorrhage is one of the first cause of maternal death, postpartum hemorrhage, which accounted for 85% of obstetric hemorrhage. And 2h postpartum hemorrhage and postpartum hemorrhage accounting for 90% of the world about 40,000 pregnant women each year die of postpartum hemorrhage [1]. thereby reducing the amount of bleeding 2 h after delivery is to reduce the rate of maternal mortality and puerperal key. postpartum hemorrhage There are four rea